Research output per year
Research output per year
Equipments Details
Description
Monash Histology Platform (MHP) is a world class, full service histology laboratory operating to international quality standards and certified to ISO 9001. MHP supports the local and national research community, providing specialised services, training and consultation. We provide all paraffin, frozen section, methacrylate and epoxy resin processing, sectioning and staining services, in addition to slide scanning and digital imaging, tissue microarray generation and automated immunohistochemical staining. Our delivery of consistent, high quality and timely outputs, in all aspects of histology, assists researchers in the delivery of highly innovative, cutting edge research outputs.
-
An unconventional T cell nexus drives HCK-mediated chronic obstructive pulmonary disease in mice
Hsu, A. T., O'Donoghue, R. J. J., Tsantikos, E., Gottschalk, T. A., Borger, J. G., Gherardin, N. A., Xu, C., Koay, H. F., Godfrey, D. I., Ernst, M., Anderson, G. P. & Hibbs, M. L., May 2025, In: EBioMedicine. 115, 24 p., 105707.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Endothelial -targeted CD39 is protective in a mouse model of global forebrain ischaemia
Lee, N. T., Savvidou, I., Selan, C., Wright, D. K., Brkljaca, R., Chia, J. S. J., Calvello, I., Craenmehr, D. D. D., Larsson, P., Tarlac, V., Vuong, A., Carmichael, I., Wang, X., Peter, K., Robson, S. C., Nandurkar, H. H. & Sashindranath, M., Dec 2025, In: Journal of Neuroinflammation. 22, 1, 13 p., 115.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Gasdermin E deficiency limits inflammation and lung damage during influenza virus infection
Rosli, S., Ambrose, R. L., Harpur, C. M., Lam, M., Hodges, C., Barry, K. T., West, A. C., Mansell, A., Lawlor, K. E. & Tate, M. D., 6 Jun 2025, In: Cell Death & Disease. 16, 1, 13 p., 440.Research output: Contribution to journal › Article › Research › peer-review
Open Access
-
Advancing Ovarian Granulosa Cell Tumor Treatment: Structural Insights and Drug Discovery for the FOXL2C134W Mutation
Chu, S. (Primary Chief Investigator (PCI)), Wong, W. (Chief Investigator (CI)), Fuller, P. (Chief Investigator (CI)), Jobling, T. (Associate Investigator (AI)), Rosenbluh, S. (Associate Investigator (AI)) & Silke, J. (Associate Investigator (AI))
1/07/25 → 30/06/28
Project: Research
-
Developing interferon epsilon as a novel immunotherapy for ovarian cancer: identification of an optimal formulation for enhanced efficacy and tolerability.
Campbell, N. (Primary Chief Investigator (PCI)), Hertzog, P. (Chief Investigator (CI)), Gearing, J. (Associate Investigator (AI)) & Ho, G.-Y. (Associate Investigator (AI))
1/07/25 → 30/06/28
Project: Research
-
Nanorobotics Vaccine-boosted CAR-T Immunotherapy for Treating Diffuse Intrinsic Pontine Glioma: A Preclinical Study
Yang, Y. (Primary Chief Investigator (PCI)), Gargett, T. (Chief Investigator (CI)), Hansford , J. R. (Chief Investigator (CI)), Pitson, S. (Chief Investigator (CI)), Zhao, C. (Chief Investigator (CI)), Tang, J. (Chief Investigator (CI)), Brown, M. (Associate Investigator (AI)), Wells, A. (Associate Investigator (AI)) & Jukes, A. (Associate Investigator (AI))
1/04/25 → 31/03/29
Project: Research